Combination chemotherapy with Cisplatin (CDDP) and Adriamycin (ADM) plus immunotherapy with interferon (IFN) alfa-2b in malignant pleural mesothelioma (MPM): results of a phase II trial of the Italian Group on Rare Tumors (GITR) and Italian Lung Cancer Task Force (FONICAP)
Parra, H.Soto, Bretti, S., Ardizzoni, A., Tixi, L., Latteri, F., Gravina, A., Lionetto, R., Bruzzi, P., Santoro, A., Rosso, R.Volume:
35
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(99)81441-5
Date:
September, 1999
File:
PDF, 167 KB
english, 1999